Ibogaine News · Tuesday, September 22, 2026

Presley Gerber's death highlights ibogaine treatment

Cindy Crawford's son advocated for ibogaine before his passing.

Presley Gerber's death and ibogaine advocacy

Presley Gerber, the son of supermodel Cindy Crawford, died at the age of 27 while in a rehabilitation facility, according to Fox News. His death, which occurred on September 20, is being investigated as a suspected overdose by the Santa Monica Police Department.

Gerber's journey with ibogaine treatment

Months before his passing, Gerber had openly discussed his struggles with addiction and his hopes for recovery through ibogaine treatment. In March, he shared a video on social media about preparing for an "ibogaine flood dose" at a wellness clinic in Cancún, Mexico. Ibogaine, a psychoactive substance derived from the Tabernanthe iboga shrub, is being studied for its potential to treat opioid and cocaine addiction, according to Stanford Medicine. However, it remains illegal in the United States.

Family support and public openness

Throughout his recovery journey, Gerber received public support from his family, including his parents, Cindy Crawford and Rande Gerber, and his sister, Kaia Gerber. They praised his courage and openness about his mental health struggles. In a 2023 podcast, Gerber expressed his desire to help others by sharing his experiences with depression and addiction.

Why it matters

Gerber's death underscores the ongoing challenges of addiction recovery and the potential role of alternative treatments like ibogaine. His openness about his struggles highlights the importance of addressing mental health issues and seeking support. As ibogaine remains a controversial treatment, Gerber's story may contribute to the broader conversation about its potential benefits and risks.

Presley Gerber's advocacy for mental health awareness and addiction recovery continues to resonate, even after his untimely death.

Sources

Reporting based on foxnews.com. Read the original in the Sources section above.

Get the newsletter

Ibogaine news, in your inbox.

Occasional dispatches. No spam.